APOA1 and Alzheimer disease: Patients with AD showed a tendency toward higher CSF ApoA-I levels compared with HCs, although this difference was non-significant [SMD = 0.20; 95% CI (−0.16, 0.56); P = 0.273; Figure 5], so further analysis was not conducted.